Literature DB >> 22791727

Pyoderma gangrenosum.

Sanwar Agrawal1, Bharat Singhania.   

Abstract

A 3.5-year-old girl presented with skin lesions beginning as a small pustule that progressed to very painful large ulcer with rolled up edges and irregular borders. At presentation, active ulcers were present over the left elbow. There were healed ulcers with scarring present on the chest, back, both thighs and abdominal wall. This child had negative antinuclear antibody, cytoplasmic antinuclear cytoplasmic antibody, antiphospholipid antibodies and tests for hepatitis B and C. She did not have any symptoms to suggest ulcerative colitis. Her colonoscopy was absolutely normal. Histopathology from her skin lesion was consistent with pyoderma gangrenosum.

Entities:  

Mesh:

Year:  2010        PMID: 22791727      PMCID: PMC3028093          DOI: 10.1136/bcr.04.2010.2942

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Diagnosing pyoderma gangrenosum.

Authors:  J T Trent; R S Kirsner
Journal:  Adv Skin Wound Care       Date:  2001 May-Jun       Impact factor: 2.347

Review 2.  Pyoderma gangrenosum: an update.

Authors:  Jeffrey P Callen; J Mark Jackson
Journal:  Rheum Dis Clin North Am       Date:  2007-11       Impact factor: 2.670

3.  Pyoderma gangrenosum in an infant.

Authors:  Antonio Torrelo; Isabel Colmenero; Cristina Serrano; Ana Vilanova; Ramón Naranjo; Antonio Zambrano
Journal:  Pediatr Dermatol       Date:  2006 Jul-Aug       Impact factor: 1.588

4.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Authors:  T N Brooklyn; M G S Dunnill; A Shetty; J J Bowden; J D L Williams; C E M Griffiths; A Forbes; R Greenwood; C S Probert
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

Review 5.  Pyoderma gangrenosum: a review and update on new therapies.

Authors:  Jeremiah Miller; Brad A Yentzer; Adele Clark; Joseph L Jorizzo; Steven R Feldman
Journal:  J Am Acad Dermatol       Date:  2010-04       Impact factor: 11.527

Review 6.  Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.

Authors:  W P Daniel Su; Mark D P Davis; Roger H Weenig; Frank C Powell; Harold O Perry
Journal:  Int J Dermatol       Date:  2004-11       Impact factor: 2.736

7.  Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum.

Authors:  Y Adachi; A L Kindzelskii; G Cookingham; S Shaya; E C Moore; R F Todd; H R Petty
Journal:  J Invest Dermatol       Date:  1998-08       Impact factor: 8.551

Review 8.  Treatment of pyoderma gangrenosum with intravenous immunoglobulin.

Authors:  D L Cummins; G J Anhalt; T Monahan; J H Meyerle
Journal:  Br J Dermatol       Date:  2007-10-04       Impact factor: 9.302

9.  Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome.

Authors:  M H Schmid; C Hary; B Marstaller; B Konz; C M Wendtner
Journal:  Eur J Dermatol       Date:  1998 Jan-Feb       Impact factor: 3.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.